Evidence map›Paper›PMID 33067399›Full record

ArticleImmunoHorizons2020

Mass Cytometry Analysis of the NK Cell Receptor-Ligand Repertoire Reveals Unique Differences between Dengue-Infected Children and Adults.

Julia L McKechnie, Davis Beltrán, Anne-Maud M Ferreira, Rosemary Vergara, Lisseth Saenz, Ofelina Vergara, Dora Estripeaut, Ana B Araúz, Laura J Simpson, Susan Holmes and 2 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in ImmunoHorizons, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Profiling of the Human Natural Killer Cell Receptor-Ligand Repertoire.Journal of visualized experiments : JoVE · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Julia L McKechnieProgram in Immunology, Stanford University School of Medicine, Stanford, CA 94305.
Davis BeltránDepartment of Research in Virology and Biotechnology, Gorgas Memorial Institute for Health Studies, Panama City, Panama.
Anne-Maud M FerreiraDepartment of Statistics, Stanford University, Stanford, CA 94305.
Rosemary VergaraDepartment of Medicine, Stanford University School of Medicine, Stanford, CA 94305.
Lisseth SaenzDepartment of Research in Virology and Biotechnology, Gorgas Memorial Institute for Health Studies, Panama City, Panama.
Ofelina VergaraHospital del Niño Doctor José Renán Esquivel, Panama City, Panama.
Dora EstripeautHospital del Niño Doctor José Renán Esquivel, Panama City, Panama.ORCID 0000-0002-2042-0817
Ana B AraúzHospital Santo Tomas, Panama City, Panama; and.ORCID 0000-0001-5880-8908
Laura J SimpsonDepartment of Medicine, Stanford University School of Medicine, Stanford, CA 94305.
Susan HolmesDepartment of Statistics, Stanford University, Stanford, CA 94305.ORCID 0000-0002-2208-8168
Sandra López-VergèsDepartment of Research in Virology and Biotechnology, Gorgas Memorial Institute for Health Studies, Panama City, Panama.ORCID 0000-0002-1106-8479
Catherine A BlishProgram in Immunology, Stanford University School of Medicine, Stanford, CA 94305.
Stanford University · USHospital del Niño · PAInstituto Conmemorativo Gorgas de Estudios de la Salud · PASaint Thomas Hospital · PAUniversidad de Panamá · PA

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Natural killer cells in Zika virus pathogenesisR21AI135287 · NIAID · STANFORD UNIVERSITY · PI BLISH, CATHERINE A · 2018 to 2019
$420k
Diagnostic signatures of Zika virus pathogenesisR21AI130523 · NIAID · STANFORD UNIVERSITY · PI BLISH, CATHERINE A · 2017 to 2018
$400k
NIAID NIH HHS R21 AI130523NIAID NIH HHS R21 AI135287NIAID NIH HHS T32 AI007290
6 · The paper itself

Abstract

Dengue virus (DENV) is a significant cause of morbidity in many regions of the world, with children at the greatest risk of developing severe dengue. NK cells, characterized by their ability to rapidly recognize and kill virally infected cells, are activated during acute DENV infection. However, their role in viral clearance versus pathogenesis has not been fully elucidated. Our goal was to profile the NK cell receptor-ligand repertoire to provide further insight into the function of NK cells during pediatric and adult DENV infection. We used mass cytometry to phenotype isolate NK cells and PBMCs from a cohort of DENV-infected children and adults. Using unsupervised clustering, we found that pediatric DENV infection leads to a decrease in total NK cell frequency with a reduction in the percentage of CD56

Indexed as

AdolescentAdultAntibodies, MonoclonalBiomarkersCD57 AntigensChildChild, PreschoolDengueFas Ligand ProteinFemaleFlow CytometryHumansKiller Cells, NaturalLymphocyte ActivationMaleMiddle AgedAntibodies, MonoclonalBiomarkersCD57 AntigensFas Ligand ProteinPerforinReceptors, Natural Killer Cell

Identifiers

PMID33067399
PMCPMC8608029
OpenAlexW3093365070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.